Role of baricitinib in COVID-19 patients: A systematic review and meta-analysis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 4

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

127

WORD

HTML

1009

Figures (1-4)

219

Tables (1-4)

212

Sum=1613

Apr 18, 2023 (publication date) through Nov 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Meta-Analysis

ISSN

2308-3840

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Meta-Analysis

World J Meta-Anal. Apr 18, 2023; 11(4): 125-133
Published online Apr 18, 2023. doi: 10.13105/wjma.v11.i4.125

Table 3 Quality assessment of observational studies using new castle Ottawa scale

*For each numbered item within the selection and outcome categories.

Citation: Thakur M, Babu A, Khatik GL, Datusalia AK, Khatri R, Kumar A. Role of baricitinib in COVID-19 patients: A systematic review and meta-analysis. World J Meta-Anal 2023; 11(4): 125-133
URL: https://www.wjgnet.com/2308-3840/full/v11/i4/125.htm
DOI: https://dx.doi.org/10.13105/wjma.v11.i4.125